Global Specialty Drug Distribution Market Size, Status and Forecast 2020-2026
Specialty Drug Distribution is a link of pharmaceutical logistics; it distributes Specialty Drug to consumers relying on certain logistics equipment, technology and logistics management information system. Specialty drugs play an increasingly important role in the treatment of chronic conditions such as multiple sclerosis (MS), rheumatoid arthritis (RA), psoriasis, and inflammatory bowel disease (IBD), etc.
The global average gross margin of specialty drug distribution is in the decreasing trend, from 7.85% in 2011 to5.97% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The type of specialty drugs includes oncology, rheumatoid arthritis, multiple sclerosis, hemophilia and others. The proportion of oncology drugs in 2015 is about 45.8%, and the proportion of rheumatoid arthritis drug in 2015 is about 15.4%.
Specialty drugs are widely sold by retail, home health, clinics, and pharmacies. The most proportion of specialty drugs are sold by clinics and the market share in 2015 is about 37.6%.
North America region is the largest supplier of specialty drug distribution, with a sales revenue market share nearly 45.6% in 2015. Europe is the second largest supplier of specialty drug distribution, enjoying sales revenue market share about 31.7% in 2015.
Market competition is intense between the giant, Amerisource, Mckesson, Cardinal Health, etc. are the leaders of the industry in North America, PHOENIX, Alliance Healthcare, Celesio, etc. are the leaders of the industry in Europe and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Specialty Drug Distribution Market
In 2019, the global Specialty Drug Distribution market size was US$ 813.9 million and it is expected to reach US$ 1803.2 million by the end of 2026, with a CAGR of 11.9% during 2021-2026.
Global Specialty Drug Distribution Scope and Market Size
Specialty Drug Distribution market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Drug Distribution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Specialty Drug Distribution market is segmented into Oncology, Rheumatoid Arthritis, Multiple Sclerosis, Hemophilia, etc.
Segment by Application, the Specialty Drug Distribution market is segmented into Retail, Home Health, Clinics, Pharmacies, etc.
Regional and Country-level Analysis
The Specialty Drug Distribution market is analysed and market size information is provided by regions (countries).
The key regions covered in the Specialty Drug Distribution market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Specialty Drug Distribution market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Specialty Drug Distribution business, the date to enter into the Specialty Drug Distribution market, Specialty Drug Distribution product introduction, recent developments, etc.
The major vendors include Amerisource, Mckesson, Cardinal Health, PHOENIX, Medipal Holdings, Alliance Healthcare, Celesio, Sinopharm, Accredo, Shanghai Pharma, Anda, Jointown, Max Pharma, Avella, etc.
This report focuses on the global Specialty Drug Distribution status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Specialty Drug Distribution development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
Amerisource
Mckesson
Cardinal Health
PHOENIX
Medipal Holdings
Alliance Healthcare
Celesio
Sinopharm
Accredo
Shanghai Pharma
Anda
Jointown
Max Pharma
Avella
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Retail
Home Health
Clinics
Pharmacies
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
To analyze global Specialty Drug Distribution status, future forecast, growth opportunity, key market and key players.
To present the Specialty Drug Distribution development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Specialty Drug Distribution are as follows:
History Year: 2015-2019
2019
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
The global average gross margin of specialty drug distribution is in the decreasing trend, from 7.85% in 2011 to5.97% in 2015. With the situation of global economy, gross margin will be in decreasing trend in the following five years.
The type of specialty drugs includes oncology, rheumatoid arthritis, multiple sclerosis, hemophilia and others. The proportion of oncology drugs in 2015 is about 45.8%, and the proportion of rheumatoid arthritis drug in 2015 is about 15.4%.
Specialty drugs are widely sold by retail, home health, clinics, and pharmacies. The most proportion of specialty drugs are sold by clinics and the market share in 2015 is about 37.6%.
North America region is the largest supplier of specialty drug distribution, with a sales revenue market share nearly 45.6% in 2015. Europe is the second largest supplier of specialty drug distribution, enjoying sales revenue market share about 31.7% in 2015.
Market competition is intense between the giant, Amerisource, Mckesson, Cardinal Health, etc. are the leaders of the industry in North America, PHOENIX, Alliance Healthcare, Celesio, etc. are the leaders of the industry in Europe and they hold key technologies and patents, with high-end customers; have been formed in the monopoly position in the industry.
Market Analysis and Insights: Global Specialty Drug Distribution Market
In 2019, the global Specialty Drug Distribution market size was US$ 813.9 million and it is expected to reach US$ 1803.2 million by the end of 2026, with a CAGR of 11.9% during 2021-2026.
Global Specialty Drug Distribution Scope and Market Size
Specialty Drug Distribution market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Specialty Drug Distribution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Specialty Drug Distribution market is segmented into Oncology, Rheumatoid Arthritis, Multiple Sclerosis, Hemophilia, etc.
Segment by Application, the Specialty Drug Distribution market is segmented into Retail, Home Health, Clinics, Pharmacies, etc.
Regional and Country-level Analysis
The Specialty Drug Distribution market is analysed and market size information is provided by regions (countries).
The key regions covered in the Specialty Drug Distribution market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.
Competitive Landscape
and Specialty Drug Distribution Market Share AnalysisSpecialty Drug Distribution market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Specialty Drug Distribution business, the date to enter into the Specialty Drug Distribution market, Specialty Drug Distribution product introduction, recent developments, etc.
The major vendors include Amerisource, Mckesson, Cardinal Health, PHOENIX, Medipal Holdings, Alliance Healthcare, Celesio, Sinopharm, Accredo, Shanghai Pharma, Anda, Jointown, Max Pharma, Avella, etc.
This report focuses on the global Specialty Drug Distribution status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Specialty Drug Distribution development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Amerisource
Mckesson
Cardinal Health
PHOENIX
Medipal Holdings
Alliance Healthcare
Celesio
Sinopharm
Accredo
Shanghai Pharma
Anda
Jointown
Max Pharma
Avella
Market segment by Type, the product can be split into
Oncology
Rheumatoid Arthritis
Multiple Sclerosis
Hemophilia
Market segment by Application, split into
Retail
Home Health
Clinics
Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Specialty Drug Distribution status, future forecast, growth opportunity, key market and key players.
To present the Specialty Drug Distribution development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.
In this study, the years considered to estimate the market size of Specialty Drug Distribution are as follows:
History Year: 2015-2019
Base Year:
2019Estimated Year:
2020Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
